20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived ...
4 February 2025 Former DLA Piper partner Melissa Harwood joins firm’s chemistry and life sciences team | Brings experience in biotechnology, therapeutics, and chemical industries.
24 January 2025 New recruit brings expertise in developing and prosecuting complex patent portfolios for small molecule drug products | Partner joins from New York law firm Fenwick & West.
Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.
Whoop faces suit over tech in health tracker watch ...
LSIPR sister title releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing ...
Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma ...
29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the ...
15 February 2024 Judge says UK courts should depart from a European precedent following Brexit | MSD counsel says appeal had ...
Former DLA Piper partner Melissa Harwood joins firm’s chemistry and life sciences team | Brings experience in biotechnology, therapeutics, and chemical industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback